Table 2.
Hospitalization rate ratios of CVDs in 2020 compared to the two-year period of 2018–2019.
| HRR (95% CI) | p-Value * + | |
|---|---|---|
| STEMI | ||
| 2020 vs. 2018–2019 | 0.93 (0.92–0.94) | <0.001 |
| Male vs. female | 0.99 (0.98–1.00) | 0.331 |
| Age | ||
| 18–44 | Ref. | |
| 45–74 | 0.99 (0.98–1.00) | 0.523 |
| ≥75 | 0.99 (0.98–1.01) | 0.948 |
| N-STEMI | ||
| 2020 vs. 2018–2019 | 0.89 (0.88–0.90) | <0.001 |
| Male vs. female | 1.00 (0.99–1.00) | 0.338 |
| Age | ||
| 18–44 | Ref. | |
| 45–74 | 0.99 (0.97–1.00) | 0.062 |
| ≥75 | 0.98 (0.97–0.99) | 0.015 |
| ACS | ||
| 2020 vs. 2018–2019 | 0.90 (0.89–0.90) | <0.001 |
| Male vs. female | 1.00 (1.00–1.00) | 0.003 |
| Age | ||
| 18–44 | Ref. | |
| 45–74 | 0.99 (0.99–1.00) | 0.925 |
| ≥75 | 1.00 (0.89–0.90) | 0.978 |
| HF | ||
| 2020 vs. 2018–2019 | 0.73 (0.73–0.73) | <0.001 |
| Male vs. female | 1.00 (0.99–1.00) | 0.073 |
| Age | ||
| 18–44 | Ref. | |
| 45–74 | 1.00 (0.99–1.00) | 0.312 |
| ≥75 | 1.00 (0.99–1.00) | 0.186 |
* All models were adjusted for hospital. + Poisson regression. STEMI: ST-segment-elevation myocardial infarction; N-STEMI: non-ST-segment-elevation myocardial infarction; ACS: acute coronary syndrome; HF: Heart failure; LOS: length of stay; 95% CI: 95% confidence interval; IQR: interquartile range.